Artificial Intelligence (AI) is set to revolutionise industries in 2025, with emerging technologies such as Agentic AI, MLOps platforms, and foundational models driving unprecedented advancements in ...

Vertex Pharmaceuticals Incorporated today announced several updates on the Company's type 1 diabetes (T1D) portfolio. VX-264 Update Vertex has completed enrollment and dosing in Parts A and B of the ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corp. (MSFT), NVIDIA Corp.

Google has announced that Gemini 2.5 Pro is now also free to use. Last week, only paying Advanced users had access to ...

Google has announced that it is updating its flagship series of Gemini artificial intelligence models by introducing an ...

Expanding CRISPR's Potential Since its discovery, CRISPR (“Clustered Regularly Interspaced Short Palindromic Repeats”), which ...

Vertex Software faces strong competition and slower growth, leading to a neutral rating. See why VERX stock remains pricey ...

Vertex's cloud growth momentum remains strong, with a 27% y/y increase in 4Q24. Read more to see why I upgrade VERX stock ...

Vertex also has a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including ...

It will be available on Vertex AI in the coming weeks. The wider rollout is expected to reach countries and territories around the world in the near future. “As always, we welcome feedback so we ...